期刊文献+

布洛芬L-抗坏血酸酯的合成及镇痛活性 被引量:3

Synthesis and Analgesic Activity of Ibuprofen L-Ascorbic Acid Ester
原文传递
导出
摘要 布洛芬和L-抗坏血酸在叔丁醇中,用Novozym 435固定化脂肪酶催化制得布洛芬L-抗坏血酸酯,收率30%,纯度大于98%。热板试验和乙酸扭体试验的结果表明,与布洛芬和布洛芬精氨酸盐相比,布洛芬L-抗坏血酸酯镇痛作用显著。 Ibuprofen L-ascorbic acid ester was synthesized from ibuprofen and L-ascorbic acid in tert-butyl alcohol catalyzed by Novozyme 435 lipase with a yield of 30 % and purity of 98 %. The results of acetic acid writhing test and hot-plate tes showed that ibuprofen L-ascorbic acid ester had significant analgesic activity compared with ibuprofen and ibuprofen arginine salt.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2011年第1期11-13,共3页 Chinese Journal of Pharmaceuticals
关键词 布洛芬 布洛芬L-抗坏血酸酯 前药 布洛芬精氨酸盐 镇痛活性 ibuprofen ibuprofen L-ascorbic acid ester pro-durg ibuprofen arginine salt analgesic activity
  • 相关文献

参考文献9

  • 1Babiloni C, Frisoni GB, Percio CD, et al. Ibuprofen treatment modifies cortical sources of EEG rhythms in mild Alzheimer's disease[J]. Clin Neurophysiol, 2009, 120 (4) : 709-718.
  • 2Bennett WM, Henrich WL, Stoff JS. The renal effects of non-steroidal anti-inflammatory drugs: summary and recommendations [J]. Am J Kidney Dis, 1996, 28 (1Suppl 1) : $56-$62.
  • 3Gimewo Navarro A, Cano Sanchez A, Femandez Gilino C, et al. Ibuprofen versus indomethacin in the treatment of patent ductus arteriosus in preterm infants [J]. An Pediatr(Barc), 2005, 63 (3) : 212-218.
  • 4Lanas A, Sopefia F. Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications [J]. Gastroenterol Clin North Am, 2009, 38 (2) : 333-352.
  • 5Palma S, Jimene-Kairuz A, Fratoni L, et al. Coagels from alkanoyl-6-O-ascorbate acid derivatives as drug carriers: structure and rheology [J]. Farmaco, 2003, 58 (12) : 1271-1276.
  • 6刘鹏,张昱,郭丽.L-天冬氨酸六肽-布洛芬的合成[J].华西药学杂志,2007,22(1):49-50. 被引量:8
  • 7FDA Approves Injectable Form of Ibuprofen[EB/OL]. [2010-01-04]. http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm 165971 .htm.
  • 8郑虎.药物化学[M].北京:人民卫生出版社,2004,297-298.
  • 9汤鲁宏,张浩.非水相脂肪酶催化合成L-抗坏血酸棕榈酸酯的研究Ⅰ[J].生物工程学报,2000,16(3):363-367. 被引量:23

二级参考文献8

  • 1何谷,黄维,郭丽.混合酸酐法合成CCK-4[J].华西药学杂志,2005,20(6):518-520. 被引量:3
  • 2Shohei Kasugai,Ryuichi Fujisawa,Yoshihiro Waki,et al.Selective drug delivery system to bone:small peptide (Asp)6 conjugation[J].J Bone Miner Res,2000,15(5):936.
  • 3K Yokogawa,K Miya,T Sekido,et al.Selective delivery of estradiol to bone by aspartic acid oligopeptide and its effects on ovariectomized mice[J].Endocrinology,2001,142:1228-1233.
  • 4Hideki Hirabayashi,Jiro Fusisaki.Bone-specific drug delivery systems[J].Clin pharmacokinet,2003,42 (15):1319-1330.
  • 5D Wang,Scott C Miller,Pavla kopeckova,et al.Bone-targeting macromolecular therapeutics[J].Adv Drug Deliv Rev,2005,57:1049-1076.
  • 6Vaughan JR,Osato RL.Preparation of peptides using mixed carboxylic acid anhydrides[J].J Am Chem Soc,1951,73:5553.
  • 7汤鲁宏,孙云飞,张浩.薄层扫描法测定L-抗坏血酸棕榈酸酯[J].食品工业科技,1999,20(5):57-58. 被引量:16
  • 8郑虎,黄文才,楼荣良,翁玲玲.与骨靶向药物有关的骨亲和性化合物的研究进展[J].药学学报,2003,38(1):75-78. 被引量:18

共引文献33

同被引文献19

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部